Guillermo Garcia-Manero

Guillermo Garcia-Manero

Corporate Officer/Principal bei Amphivena Therapeutics, Inc.

Retail Trade

Ursprung des Netzwerks ersten Grades von Guillermo Garcia-Manero

EinheitArt der EinheitIndustrie
6
Holding Company Drugstore Chains 6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Guillermo Garcia-Manero

UnternehmenSektorVerknüpfte PersonenHauptposition
INTERMUNE INC Biotechnology

Peter van Vlasselaer

Corporate Officer/Principal

Medical Specialties

Luke Evnin

Director/Board Member

Biotechnology

Peter van Vlasselaer

Chairman

SQZ BIOTECHNOLOGIES COMPANY Biotechnology

Eric Moessinger

Director/Board Member

Investment Managers

Peter van Vlasselaer

Private Equity Investor

UCB Pharmaceuticals: Major

Mark McDade

Chief Operating Officer

Investment Managers

Chris Richard

Analyst-Equity

LUPIN LIMITED Pharmaceuticals: Other

Mark McDade

Director/Board Member

New York University College/University

Chris Richard

Graduate Degree

University of Florida College/University

Eric Moessinger

Undergraduate Degree

Investment Managers

Chris Richard

Private Equity Analyst

London School of Economics & Political Science College/University

Eric Moessinger

Graduate Degree

Investment Managers

Eric Moessinger

peter vlasselaer

Private Equity Investor

Private Equity Investor

Medical Specialties

Chris Richard

Corporate Officer/Principal

Université Catholique de Louvain College/University

Peter van Vlasselaer

Doctorate Degree

Miscellaneous Commercial Services

Peter van Vlasselaer

Chief Executive Officer

Financial Conglomerates

Mark McDade

Corporate Officer/Principal

Biotechnology

Mark McDade

Director/Board Member

Pharmaceuticals: Major

Mark McDade

Director/Board Member

Electronic Equipment/Instruments

Eric Moessinger

Director/Board Member

Internet Software/Services

Mark McDade

Director/Board Member

Pharmaceuticals: Major

Peter van Vlasselaer

Chairman

Miscellaneous Commercial Services

Mark McDade

Director/Board Member

Biotechnology

Eric Moessinger

Director/Board Member

ARMO BIOSCIENCES INC Pharmaceuticals: Major

Peter van Vlasselaer

Founder

Biotechnology

Chris Richard

Director/Board Member

Drugstore Chains

Eric Moessinger

Director/Board Member

Pharmaceuticals: Major

Peter van Vlasselaer

peter vlasselaer

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Luke Evnin

Peter van Vlasselaer

peter vlasselaer

Founder

Director/Board Member

Director/Board Member

Medical/Nursing Services

Mark McDade

Director/Board Member

Medical Specialties

Mark McDade

Director/Board Member

Miscellaneous Commercial Services

Mark McDade

Director/Board Member

LEAP THERAPEUTICS, INC. Biotechnology

Chris Richard

Director/Board Member

Real Estate Investment Trusts

Mark McDade

Director/Board Member

Real Estate Investment Trusts

Mark McDade

Director/Board Member

Investment Managers

Chris Richard

Private Equity Investor

Medical Specialties

Mark McDade

Director/Board Member

Investment Managers

Mark McDade

Founder

Miscellaneous Commercial Services

Eric Moessinger

Director/Board Member

Pharmaceuticals: Major

Peter van Vlasselaer

peter vlasselaer

Chairman

Director/Board Member

ICOSAVAX, INC. Pharmaceuticals: Major

Mark McDade

Eric Moessinger

Chairman

Director/Board Member

Investment Managers

peter vlasselaer

Private Equity Investor

Internet Software/Services

Mark McDade

Director/Board Member

Miscellaneous Commercial Services

Eric Moessinger

Director/Board Member

Miscellaneous Commercial Services

Eric Moessinger

Director/Board Member

Biotechnology

Peter van Vlasselaer

peter vlasselaer

Founder

Chief Executive Officer

Statistik

International

Vereinigte Staaten 44
Belgien 3
Vereinigtes Königreich 3
Indien 2
Schweiz 2

Sektoral

Health Technology 24
Finance 11
Commercial Services 8
Consumer Services 5
Technology Services 3

Operativ

Director/Board Member 72
Independent Dir/Board Member 18
Chairman 16
Founder 14
Chief Executive Officer 9